SCHEMBL7563969

SCHEMBL7563969

CCNCCCCC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.54
ADRA1A P35348 1/20 0.54
LMNA P02545 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 5/20 0.52
PTPN1 P18031 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28622058 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
SCHEMBL31536450 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
SCHEMBL2209285 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
Azelaic Acid SCHEMBL11513754 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
SCHEMBL21634549 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
SCHEMBL11540844 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
SCHEMBL9259807 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
SCHEMBL172839 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
SCHEMBL11516867 0.98 ADRA1A (0.57) AKR1B1ADRA1ALMNAGPR84PPARG
Hydrochloric Acid SCHEMBL28197489 0.98 AKR1B1 (0.52) AKR1B1ADRA1ALMNACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626374-B1 A diaminostilbene series compound and a method for forming an image using the same FUJI PHOTO FILM CO LTD (JP) 2002-08-07 EP claimed
US-5395742-A IMAGEWISE EXPOSURE OF A PHOTOGRAPHIC MATERIAL TO LIGHT FUJI PHOTO FILM CO., LTD. (JP) 1995-03-07 US claimed
EP-0626374-A2 A diaminostilbene series compound and a method for forming an image using the same FUJI PHOTO FILM CO., LTD. (JP) 1994-11-30 EP claimed
EP-3985002-A1 ARYL, HETEROARY, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2022-04-20 EP disclosed
US-20200317722-A1 SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE BRACCO IMAGING S.P.A. (IT) 2020-10-08 US disclosed
US-9811014-B2 Yellow toner and production method therefor CANON KABUSHIKI KAISHA (JP) 2017-11-07 US disclosed
US-20150378273-A1 YELLOW TONER AND PRODUCTION METHOD THEREFOR CANON KABUSHIKI KAISHA (JP) 2015-12-31 US disclosed
CN-103323592-B High-throughput drug rapid detection chip and system ZENG LIBO (CN) 2015-09-23 CN disclosed
CN-103323592-A High-throughput drug rapid detection chip and system ZENG LIBO 2013-09-25 CN disclosed
EP-0626374-B1 A diaminostilbene series compound and a method for forming an image using the same FUJI PHOTO FILM CO LTD (JP) 2002-08-07 EP disclosed
EP-0631185-B1 Method for continuously processing silver halide color photosensitive material FUJI PHOTO FILM CO LTD (JP) 1997-01-02 EP disclosed
US-5395742-A IMAGEWISE EXPOSURE OF A PHOTOGRAPHIC MATERIAL TO LIGHT FUJI PHOTO FILM CO., LTD. (JP) 1995-03-07 US disclosed
US-5391467-A Covering surface of color developer replenisher with layer of floating liquid; inhibiting precipitation FUJI PHOTO FILM CO., LTD. (JP) 1995-02-21 US disclosed
EP-0631185-A1 Method for continuously processing silver halide color photosensitive material Fuji Photo Film Co., Ltd. (JP) 1994-12-28 EP disclosed
EP-0626374-A2 A diaminostilbene series compound and a method for forming an image using the same FUJI PHOTO FILM CO., LTD. (JP) 1994-11-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200317722-A1 SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE MKI67, SSTR5, AURKA AKR1B1 4007/4885ADRA1A 3285/4885LMNA 3265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.